OverviewChartNewsTraderScreen

Morgan Stanley Knock-Out MRK/  DE000MB8EC02  /

Stuttgart
2024-11-07  10:58:52 AM Chg.+0.05 Bid2:15:28 PM Ask2:15:28 PM Underlying Strike price Expiration date Option type
2.78EUR +1.83% 2.78
Bid Size: 5,000		 2.82
Ask Size: 5,000		 Merck and Co Inc 71.3907 USD 2078-12-31 Call
TeleTrader 10-31 Merck's Q3 sales up 4% to $16.7 billion
GlobeNewswire 07-31 Vaccinex Reports Positive Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease
TeleTrader 07-30 Merck's Q2 sales up 7% to $16.1 billion
GlobeNewswire 07-17 Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease a...
TeleTrader 07-01 US closes higher after data
GlobeNewswire 06-27 Verizon elects Caroline A. Litchfield to its Board of Directors
GlobeNewswire 06-26 COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors
GlobeNewswire 06-11 Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...
GlobeNewswire 06-06 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
GlobeNewswire 05-30 Monte Rosa Therapeutics Announces Leadership Team Promotions
TeleTrader 05-28 US markets turn to losses, Dow plunges 330 points
GlobeNewswire 05-28 Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire 05-23 IO Biotech to Present at Jefferies Global Healthcare Conference
GlobeNewswire 05-23 atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire 05-16 Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 05-14 IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
GlobeNewswire 05-08 C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire 04-25 American Kidney Fund Launches National Kidney Health Equity Media Campaign
TeleTrader 04-25 Merck's Q1 sales rise by 9% to $15.8 billion
GlobeNewswire 04-24 IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Onc...
GlobeNewswire 04-18 The New York Academy of Medicine Announces New Board of Trustee Members
GlobeNewswire 04-15 IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
GlobeNewswire 04-09 IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer...
GlobeNewswire 04-05 IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer
GlobeNewswire 04-03 TOMI Environmental Solutions Receives Gold Safety Award from Highwire